COMMUNIQUÉS West-GlobeNewswire

-
Zafgen Announces Positive Results for Second Cohort of Phase 2 Clinical Trial of ZGN-1061
17/01/2019 -
ContraFect Announces Additional $2.3 Million in Funding from CARB-X to Support Gram-Negative Lysin Program
17/01/2019 -
Avivagen Announces CEO Letter to Shareholders
17/01/2019 -
Interim report September 1, 2018 – November 30, 2018
17/01/2019 -
PledPharma presents PledOx®’s phase III program at the Gastrointestinal (GI) Cancers Symposium
17/01/2019 -
Nicox : Point d'activité et résumé financier du quatrième trimestre 2018
17/01/2019 -
DBV Technologies: Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
17/01/2019 -
DBV Technologies : Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
17/01/2019 -
Nicox Fourth Quarter 2018 Business Update and Financial Highlights
17/01/2019 -
Spineway: 2018 revenue of €6.5M
17/01/2019 -
SPINEWAY : Chiffre d’affaires 2018 de 6,5 M€
17/01/2019 -
Golden Leaf Holdings Announces Termination of Agreement to Acquire a multi-use “Sweet 16” license and certain other assets in San Jose, California
16/01/2019 -
Assure Holdings Announces Option Issuance
16/01/2019 -
Golden Leaf Holdings Announces Termination of Agreement to Acquire the Assets of Tahoe Hydroponics
16/01/2019 -
Publication in ImmunoHorizons Highlights the Role of IL-27 in Upregulation of Multiple Checkpoint Proteins
16/01/2019 -
MannKind Announces Direct Purchase Insulin Program Providing Afrezza® for as low as $4 a Day
16/01/2019 -
Adamis’ Commercial Partner Launches SYMJEPI™ (epinephrine) in the US
16/01/2019 -
Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Horizon Blue Cross Blue Shield of New Jersey
16/01/2019 -
Sharecare names finalists for inaugural Sharecare Awards
16/01/2019
Pages